Cargando…
Combined Inhibition of Complement and CD14 Attenuates Bacteria-Induced Inflammation in Human Whole Blood More Efficiently Than Antagonizing the Toll-like Receptor 4–MD2 Complex
Background. Single inhibition of the Toll-like receptor 4 (TLR4)–MD2 complex failed in treatment of sepsis. CD14 is a coreceptor for several TLRs, including TLR4 and TLR2. The aim of this study was to investigate the effect of single TLR4-MD2 inhibition by using eritoran, compared with the effect of...
Autores principales: | Gustavsen, Alice, Nymo, Stig, Landsem, Anne, Christiansen, Dorte, Ryan, Liv, Husebye, Harald, Lau, Corinna, Pischke, Søren E., Lambris, John D., Espevik, Terje, Mollnes, Tom E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907417/ https://www.ncbi.nlm.nih.gov/pubmed/26977050 http://dx.doi.org/10.1093/infdis/jiw100 |
Ejemplares similares
-
Complement component 5 does not interfere with physiological hemostasis but is essential for Escherichia coli‐induced coagulation accompanied by Toll‐like receptor 4
por: Landsem, A., et al.
Publicado: (2018) -
Dual inhibition of complement and Toll-like receptors as a novel approach to treat inflammatory diseases—C3 or C5 emerge together with CD14 as promising targets
por: Barratt-Due, Andreas, et al.
Publicado: (2017) -
Complement C3b contributes to Escherichia coli-induced platelet aggregation in human whole blood
por: Landsem, Anne, et al.
Publicado: (2022) -
Low Levels of Immunoglobulins and Mannose-Binding Lectin Are Not Associated With Etiology, Severity, or Outcome in Community-Acquired Pneumonia
por: Siljan, William W, et al.
Publicado: (2018) -
Combined inhibition of C5 and CD14 efficiently attenuated the inflammatory response in a porcine model of meningococcal sepsis
por: Hellerud, Bernt C., et al.
Publicado: (2017)